SWX:VAHN
SWX:VAHNInsurance

European Dividend Stocks To Enhance Your Portfolio

As the European market shows resilience with the STOXX Europe 600 Index rising by 0.77% amid solid economic data and earnings results, investors are increasingly focusing on dividend stocks to bolster their portfolios. In a climate where stability and income generation are highly valued, selecting dividend stocks that align with robust financial performance and consistent payout histories can be a prudent strategy for enhancing investment portfolios.
SWX:VACN
SWX:VACNMachinery

VAT Group (SWX:VACN) Is Up 14.1% After Q4 Order Rebound Signals Renewed Demand Momentum

In January 2026, VAT Group AG reported preliminary results showing fourth-quarter 2025 net sales of CHF 257 million versus CHF 283.2 million a year earlier, and full-year 2025 net sales of CHF 1.07 billion compared with CHF 942.2 million. Despite the softer quarterly sales, fourth-quarter 2025 orders climbed to about CHF 305 million, rising both sequentially and year on year, highlighting a renewed pickup in demand that contrasts with the more muted full-year order trend. We will now...
SWX:SIKA
SWX:SIKAChemicals

A Look At Sika (SWX:SIKA) Valuation After 2025 Sales Miss And Margin Guidance Cut

Sika (SWX:SIKA) is back in focus after its 2025 trading update showed weaker sales, a lower profit margin outlook, and a sharp share price reaction as investors reassess regional and currency risks. See our latest analysis for Sika. The recent 2025 trading update and guidance cut come on top of a weaker share price trend, with a 90 day share price return of 14.17% and a 1 year total shareholder return of 32.05%. This points to fading momentum as investors reassess regional and currency...
SWX:COPN
SWX:COPNPharmaceuticals

Assessing Cosmo Pharmaceuticals (SWX:COPN) Valuation After Vision 2030 Scale Up And AI Healthtech Expansion

Why Cosmo Pharmaceuticals is Back on Investors’ Radars Cosmo Pharmaceuticals (SWX:COPN) is drawing fresh attention after management detailed a scale up phase under its Vision 2030 plan, highlighting solid finances, expanding GI Genius and Winlevi franchises, and a maturing dermatology and gastroenterology pipeline. See our latest analysis for Cosmo Pharmaceuticals. That story around Vision 2030 seems to be resonating with the market, with a 90 day share price return of 75.23% and a 1 year...
SWX:BAER
SWX:BAERCapital Markets

Do Julius Bär (SWX:BAER) Leadership Changes Clarify or Complicate Its Transformation Story?

Julius Bär Gruppe has announced past and upcoming organisational and leadership changes, appointing former HSBC executive Jean Nabaa as COO while current COO and Deputy CEO Nic Dreckmann plans to step down by April 2026, alongside the creation of a new Group Communications function to be led by experienced communicator Cindy Leggett-Flynn. By bringing in leaders with extensive international wealth management and high-stakes communications experience, Julius Bär is signaling a push to...
SWX:ZURN
SWX:ZURNInsurance

Zurich Insurance Group’s Valuation As Risk Warnings And Davos Seminar Spotlight Intensify Investor Focus

Why Zurich Insurance Group’s risk warnings are back in focus Zurich Insurance Group (SWX:ZURN) is back on investors’ radar after senior executives highlighted rising geopolitical, technological, and societal risks, ahead of the group’s upcoming presentation at the Octavian Seminar 2026 in Davos. See our latest analysis for Zurich Insurance Group. Zurich’s share price at CHF 578.8 has slipped over the year to date, yet a 90 day share price return of 4.25% sits alongside a 1 year total...
SWX:BLKB
SWX:BLKBBanks

European Dividend Stocks To Consider In January 2026

As European markets continue to show optimism with major stock indexes rising, investors are increasingly focused on the strengthening eurozone economy and favorable interest rate conditions. In this environment, dividend stocks can offer a stable income stream, making them an attractive option for those looking to capitalize on the current economic momentum while potentially benefiting from regular payouts.
SWX:DKSH
SWX:DKSHTrade Distributors

Will SBTi-Validated Net-Zero Targets Redefine DKSH Holding's (SWX:DKSH) Long-Term Resilience Narrative?

DKSH Holding AG recently received official validation from the Science Based Targets initiative that its near-term and net-zero emissions targets align with climate science and the Paris Agreement, confirming deep reductions in Scope 1, 2, and 3 emissions and a commitment to net-zero across its value chain by 2050. This independent endorsement strengthens DKSH’s sustainability positioning, underscoring how its efforts in transport optimization, renewable electricity, fleet electrification,...
SWX:ROG
SWX:ROGPharmaceuticals

Is Roche Holding (SWX:ROG) Pricing Fully Reflects Strong Multi‑Year Share Performance

If you are wondering whether Roche Holding's current share price really reflects its quality and prospects, you are not alone; many investors are asking the same question. The stock last closed at CHF 345.70, with returns of 1.9% over 7 days, 7.9% over 30 days, 6.2% year to date, 33.0% over 1 year and 31.0% over 3 years. This naturally raises questions about how much of this performance is already priced in. Recent coverage has focused on Roche Holding's position as a major global...